Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,438 signal articles · 135 in last 24h · 154,019 total before filter · latest 55m ago
135last 24h
869last 7d
144● bullish (7d)
99● bearish (7d)
214publishers
AllMacro207Earnings105M&A125Regulatory22Product21Analyst16
✕ clear all filtersticker: MXLSentiment:bullishneutralbearishshow all (incl. clickbait)
This Optical Networking Stock Has Soared This Year. Why It Fell After Strong Earnings.
Barrons.com62d agobullish
This Optical Networking Stock Has Soared This Year. Why It Fell After Strong Earnings.

The company late Thursday posted adjusted earnings of 35 cents a share, from 2 cents a year ago and above Wall Street’s 33 cents expectation. Revenue grew 55% to $168.8 million, beating the analyst consensus view of $164.6 million, according to FactSet. The earnings and revenue growth were due to strong momentum in the company’s optical artificial-intelligence date center business, and management expects that demand to continue.

MaxLinear Q2 Earnings Call Highlights
MarketBeat63d agoneutral
MaxLinear Q2 Earnings Call Highlights

MaxLinear (NASDAQ:MXL) reported a sharp increase in second-quarter 2026 revenue and returned to GAAP profitability, as executives said demand for the company’s data center optical products is driving a new growth phase. On the company’s earnings call, Chief Executive Officer Kishore Seendripu said

Bloomberg63d agobullish
Intel Needs More Than Blowout Earnings as Chips Rally Falters

(Bloomberg) -- Intel Corp. is expected to report strong second-quarter earnings after the market close Thursday, but even blowout results likely won’t be enough to reverse the stock’s July slide. Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump’s 100% Generic Drug Duty Threatens US Low-Cost SupplyApple to Launch ‘Upgrade’ Device Le